Skip to content

Clinical trials

Phase 1 trials in Bosnia and Herzegovina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Country / region: Bosnia and Herzegovina Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20161
20172
20181
20193
20203
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aileron Therapeutics, Inc.2
Archigen Biotech Limited1
Cantonal Hospital Zenica1
Center Trials & Treatment Europe1
Formycon AG1
H. Lundbeck A/S1
Heart Center BH Tuzla1
Hoffmann-La Roche1
JHL Biotech, Inc.1
Jiangsu Hansoh Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid3
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Breast Neoplasms2
Diabetes Mellitus, Type 22
Alopecia1
Carcinoma, Ovarian Epithelial1
Fallopian Tube Neoplasms1
Glioma1
Gliosarcoma1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.